Market Watch: Sizmek Inc. (NASDAQ:SZMK), Merck & Co. Inc. (NYSE:MRK), Canadian Solar Inc. (NASDAQ:CSIQ), Zendesk (NYSE:ZEN), AngloGold Ashanti Limited (ADR) (NYSE:AU)


On 11 December Sizmek Inc. (NASDAQ:SZMK) announced the appointment of Liz Ritzcovan as Global CRO. Ritzcovan joins Sizmek from Parade Media Group, part of Advance Publications /Condé Nast, where she served as CRO overseeing sales, marketing & creative teams. Liz brings a wealth of global sales management and media experience to Sizmek. Sizmek Inc. (NASDAQ:SZMK) in last trading activity advanced 5.75% to close at $6.62. Company weekly performance is 8.17% while its quarterly performance stands at -11.97%. Sizmek Inc. (NASDAQ:SZMK) is -50.04% away from its 52 week high.

On 8 December Merck & Co. Inc. (NYSE:MRK) announced a definitive agreement to acquire Cubist Pharmaceuticals, a biopharmaceutical company focused on superbugs. On last trading day Merck & Co. Inc. (NYSE:MRK) advanced 0.70% to close at $57.19. Its volatility for the week is 1.14% while volatility for the month is 1.79%. MRK’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was -16.50%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -5.19%.

On 2 January Canadian Solar Inc. (NASDAQ:CSIQ) said that it has closed the sale of the Liskeard 1 solar farm through its wholly owned subsidiary Canadian Solar Solutions. Canadian Solar Inc. (NASDAQ:CSIQ) in last trading activity advanced 2.07% to close at $24.69. Company weekly performance is 8.19% while its quarterly performance stands at -29.01%. Canadian Solar Inc. (NASDAQ:CSIQ) is -44.52% away from its 52 week high.

Zendesk, Inc (NYSE:ZEN) SVP Adrian Mcdermott sold 18,490 shares of the company’s stock in a transaction dated Friday, December 26th. The shares were sold at an average price of $25.00, for a total transaction of $462,250.00. Following the completion of the sale, the senior vice president now directly owns 82,777 shares in the company, valued at approximately $2,069,425. On Friday shares of Zendesk, Inc. (NYSE:ZEN) closed at $24.57. Company’s EPS growth for next 5 years is recorded as 35.00%.

AngloGold Ashanti Limited (ADR) (NYSE:AU) has been given an average rating of “Hold” by the ten ratings firms that are currently covering the stock. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $8.90. On last trading day AngloGold Ashanti Limited (ADR) (NYSE:AU) advanced 0.92% to close at $8.78. Its volatility for the week is 4.38% while volatility for the month is 5.64%. AU’s sales growth for past 5 years was 8.70% and its EPS growth for past 5 years was -8.10%. AngloGold Ashanti Limited (ADR) (NYSE:AU) monthly performance is -0.79%.


Leave a Reply

Your email address will not be published. Required fields are marked *